Daiichi will seek up to $2.3bn for Ranbaxy
Japanese pharmaceutical group Daiichi Sankyo may borrow up to $2.3bn to finance its purchase of a majority stake in Ranbaxy Laboratories, India’s biggest generic drug maker, EuroWeek has learned.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: